Pfizer Receives EU Support For Its RSV Vaccine

The EU drug controller, the European Medications Organization (EMA), declared Friday that a specialist board of the organization suggested showcasing endorsement for Abrysvo, created by Pfizer (NYSE: PFE), to safeguard against respiratory syncytial infection (RSV) in youngsters and more seasoned…